Ignite Creation Date:
2024-05-05 @ 11:35 AM
Last Modification Date:
2024-10-26 @ 9:10 AM
Study NCT ID:
NCT00083525
Status:
COMPLETED
Last Update Posted:
2008-01-24
First Post:
2004-05-25
Brief Title:
Urokinase-Plasminogen Activator uPA Inhibitor WX-UK1 in Combination With Capecitabine in Advanced Malignancies
Sponsor:
Heidelberg Pharma AG
Organization:
Heidelberg Pharma AG
Organization Data
Organization:
Heidelberg Pharma AG
Class:
INDUSTRY
Study ID:
WX50-005
Study Type:
None
Study Domain:
None
Study Link:
None
Lead Sponsor:
Heidelberg Pharma AG
Lead Sponsor Class:
INDUSTRY
Responsible Party:
None
Responsible Party Title:
None
Responsible Party Type:
None
Responsible Party Affiliation:
None
Old Name:
None
Old Organization:
None
Collaborators
| Name | Class |
|---|---|
| United States Department of Defense | FED |